EMAIL THIS PAGE TO A FRIEND

Biochemical and biophysical research communications

IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression.


PMID 25795135

Abstract

Interleukin (IL)-33 is a recently discovered proinflammatory cytokine that belongs to the IL-1 family. Several studies have reported that IL-33 inhibits osteoclast differentiation. However, the mechanism of IL-33 regulation of osteoclastogenesis remains unclear. In the present study, we examined the effect of IL-33 on osteoclast formation inxa0vitro. IL-33 suppressed osteoclast formation in both mouse bone marrow cells and monocyte/macrophage cell line RAW264.7 cells induced by receptor activator of NF-κB ligand (RANKL) and/or macrophage stimulating factor (M-CSF). IL-33 also inhibited the expression of RANKL-induced nuclear factor of activated T-cell cytoplasmic 1 (NFATc1), thereby decreasing the expression of osteoclastogenesis-related marker genes, including Cathepsin K, Osteoclast stimulatory transmembrane protein (Oc-stamp) and Tartrate-resistant acid phosphatase (Trap). Blockage of IL-33-ST2 binding suppressed the IL-33-mediated inhibition of NFATc1. RANKL-induced B-lymphocyte-induced maturation protein-1 (Blimp-1) expression was also suppressed by IL-33, which was followed by the stimulation of anti-osteoclastic genes such as interferon regulatory factor-8 (IRF-8). These results suggest that IL-33-ST2 interactions down-regulate both RANKL-induced NFATc1 activation and osteoclast differentiation via the regulation of Blimp-1 and IRF-8 expression.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

PRS3989
Anti-Blimp-1 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3991
Anti-Blimp-1 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA007406
Anti-IL1RL1 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2101150
Anti-IL1RL1 antibody produced in rabbit, affinity isolated antibody
HPA007917
Anti-IL1RL1 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2501378
Anti-PRDM1 (C-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501379
Anti-PRDM1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1412469
ANTI-PRDM1 antibody produced in mouse, clone 1G6, purified immunoglobulin, buffered aqueous solution
SAB1412631
ANTI-PRDM1 antibody produced in mouse, clone 4A6, purified immunoglobulin, buffered aqueous solution
HPA030033
Anti-PRDM1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104001
Anti-PRDM1 antibody produced in rabbit, affinity isolated antibody
PRS3363
Anti-ST2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA041487
Anti-SULT2A1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SRP4193 IL-33 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
SRP3275 IL-33 human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
WH0000639M1
Monoclonal Anti-PRDM1 antibody produced in mouse, clone 2B10, purified immunoglobulin, buffered aqueous solution
SAB5300402 Monoclonal Anti-PRDM1 antibody produced in mouse, clone 5E7, ascites fluid
SAB1403606
Monoclonal Anti-PRDM1, (N-terminal) antibody produced in mouse, clone 2F8, purified immunoglobulin, buffered aqueous solution
SAB4100094
Monoclonal Anti-SULT2A1 antibody produced in mouse, clone SULT2A1-A79, culture supernatant
SAB4100095
Monoclonal Anti-SULT2A1 antibody produced in mouse, clone SULT2A1-B79, culture supernatant